Please assess the completion status of the following clinical trial:

Trial Title: Autologous Platelet Lysate in Corneal Epithelial Defects

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Cognitive ability to understand and sign the consent form.~2. Corneal ulcers that did not re-epithelialise after 1 week of conventional treatment (therapeutic contact lenses, topical artificial tears, eye packs and antibiotic eye-drops).~3. Clinical indications: corneal ulcer due to caustic substances, corneal epitheliopathy, corneal lesions following cataract surgery, recurrent ulcerative keratitis, corneal lesions due to a foreign body.~4. Good compliance with the study regimen and availability for the duration of the entire study period.~Exclusion Criteria:~1. Corneal ulcers which developed tissue scars.~2. Pregnant or lactating women.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 78 Years
- Healthy Volunteers: f

Study Arms:
- Platelet Lysate (Type: EXPERIMENTAL): Autologous platelet lysate dispensed into eye droppers to be applied four times a day for a total of four weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).